Results 141 to 150 of about 3,021 (181)
Some of the next articles are maybe not open access.
Drug and Alcohol Dependence, 2020
This study examines whether MOUD increases treatment completion and retention in both short-term (ST) and long-term (LT) residential programs using a national dataset.Data were extracted from the 2015-2017 TEDS-D (Treatment Episode Dataset-Discharge) datasets for opioid using adults in ST (n = 87,296) and LT (n = 66,623) residential treatment.
Gerald J, Stahler, Jeremy, Mennis
openaire +2 more sources
This study examines whether MOUD increases treatment completion and retention in both short-term (ST) and long-term (LT) residential programs using a national dataset.Data were extracted from the 2015-2017 TEDS-D (Treatment Episode Dataset-Discharge) datasets for opioid using adults in ST (n = 87,296) and LT (n = 66,623) residential treatment.
Gerald J, Stahler, Jeremy, Mennis
openaire +2 more sources
Social Work in Mental Health, 2021
Recent decades have witnessed increases in (a) integrated physical and behavioral health services and (b) the treatment of opioid use disorders (OUD) in primary care settings – also known as office...
Lisa de Saxe Zerden +2 more
openaire +1 more source
Recent decades have witnessed increases in (a) integrated physical and behavioral health services and (b) the treatment of opioid use disorders (OUD) in primary care settings – also known as office...
Lisa de Saxe Zerden +2 more
openaire +1 more source
The Journal of Rural Health
AbstractBackgroundMedications for opioid use disorder (MOUD) programs in Emergency Departments (EDs) are feasible and effective, but uptake lags despite rising overdose deaths. NM Bridge partners with hospitals across highly rural New Mexico to guide implementation for ED‐based MOUD using a Dissemination & Implementation (D&I) approach.
Margaret Greenwood‐Ericksen +9 more
openaire +2 more sources
AbstractBackgroundMedications for opioid use disorder (MOUD) programs in Emergency Departments (EDs) are feasible and effective, but uptake lags despite rising overdose deaths. NM Bridge partners with hospitals across highly rural New Mexico to guide implementation for ED‐based MOUD using a Dissemination & Implementation (D&I) approach.
Margaret Greenwood‐Ericksen +9 more
openaire +2 more sources
Journal of Substance Use and Addiction Treatment
Individuals with opioid use disorder (OUD) transitioning from jails or prisons to the community are at high risk of overdose-related death shortly after release. Buprenorphine, methadone, and extended-release naltrexone are FDA-approved medications for opioid use disorder (MOUD) to reduce overdose risk and increase treatment engagement.
Elham, Pourtaher +4 more
openaire +2 more sources
Individuals with opioid use disorder (OUD) transitioning from jails or prisons to the community are at high risk of overdose-related death shortly after release. Buprenorphine, methadone, and extended-release naltrexone are FDA-approved medications for opioid use disorder (MOUD) to reduce overdose risk and increase treatment engagement.
Elham, Pourtaher +4 more
openaire +2 more sources
Substance Abuse, 2020
Opioid use disorder (OUD) is highly prevalent among persons who are incarcerated. Medication treatment for opioid use disorder (MOUD), methadone, buprenorphine, and naltrexone, is widely used to treat OUD in the community. Despite MOUD's well-documented effectiveness in improving health and social outcomes, its use in American jails and prisons is ...
Emma R. Brezel, Tia Powell, Aaron D. Fox
openaire +1 more source
Opioid use disorder (OUD) is highly prevalent among persons who are incarcerated. Medication treatment for opioid use disorder (MOUD), methadone, buprenorphine, and naltrexone, is widely used to treat OUD in the community. Despite MOUD's well-documented effectiveness in improving health and social outcomes, its use in American jails and prisons is ...
Emma R. Brezel, Tia Powell, Aaron D. Fox
openaire +1 more source
Substance abuse, 2021
Opioid use disorder (OUD) is highly prevalent among persons who are incarcerated. Medication treatment for opioid use disorder (MOUD), methadone, buprenorphine, and naltrexone, is widely used to treat OUD in the community. Despite MOUD's well-documented effectiveness in improving health and social outcomes, its use in American jails and prisons is ...
Emma R, Brezel +2 more
openaire +1 more source
Opioid use disorder (OUD) is highly prevalent among persons who are incarcerated. Medication treatment for opioid use disorder (MOUD), methadone, buprenorphine, and naltrexone, is widely used to treat OUD in the community. Despite MOUD's well-documented effectiveness in improving health and social outcomes, its use in American jails and prisons is ...
Emma R, Brezel +2 more
openaire +1 more source
Stigma and Medication for Opioid Use Disorder (MOUD) Among Women
International Journal of Mental Health and Addiction, 2022Jessica L. Chou +7 more
openaire +1 more source
Psychological Services
Medication for opioid use disorder (MOUD) is an evidence-based treatment for opioid use disorder (OUD). However, only a small proportion of eligible patients receive MOUD, due in part to access barriers and the complex medical needs of this population.
Brian P. O'Rourke +10 more
openaire +2 more sources
Medication for opioid use disorder (MOUD) is an evidence-based treatment for opioid use disorder (OUD). However, only a small proportion of eligible patients receive MOUD, due in part to access barriers and the complex medical needs of this population.
Brian P. O'Rourke +10 more
openaire +2 more sources
Facilitated Access to Medication for Medications for Opioid Use Disorder (MOUD) Requirements
2023openaire +1 more source